Atypical CD4(+)/CD8(+) Lymphocytosis and Prolonged Pancytopenia Associated With Human Herpesvirus 6 Reactivation After Autologous Peripheral Blood Stem Cell Transplantation
AffiliationUniv Arizona, Coll Med Tucson, Dept Med
Univ Arizona, Coll Med Tucson, Dept Pathol
Univ Arizona, Canc Ctr
MetadataShow full item record
PublisherCIG MEDIA GROUP, LP
CitationRussell, S. J., Duran, J., Fuchs, D., & Yeager, A. M. (2019). Atypical CD4+/CD8+ Lymphocytosis and Prolonged Pancytopenia Associated with Human Herpesvirus-6 Reactivation after Autologous Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 25(3), S339-S340.
Rights© 2019 Elsevier Inc. All rights reserved.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
Note12 month embargo; published online: 15 March 2019
VersionFinal accepted manuscript
- Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
- Authors: Hudnall SD, Patel J, Schwab H, Martinez J
- Issue date: 2003 Sep
- First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients.
- Authors: de Pagter AP, Boelens JJ, Scherrenburg J, Vroom-de Blank T, Tesselaar K, Nanlohy N, Sanders EA, Schuurman R, van Baarle D
- Issue date: 2012 Sep
- Expansion of a clonal CD8+CD57+ large granular lymphocyte population after autologous stem cell transplant in multiple myeloma.
- Authors: Wolniak KL, Goolsby CL, Chen YH, Chenn A, Singhal S, JayeshMehta, Peterson LA
- Issue date: 2013 Feb
- Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT).
- Authors: Reimer P, Kunzmann V, Wilhelm M, Weissbrich B, Kraemer D, Berghammer H, Weissinger F
- Issue date: 2003 May
- Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
- Authors: Steingrimsdottir H, Gruber A, Björkholm M, Svensson A, Hansson M
- Issue date: 2000 Aug